Endo Pharmaceuticals Holdings Inc. / American Medical Systems Holdings, Inc.
2011 · Acquisition/Merger · $2.9B · Complete
Announcement Sentiment
67
Positive
Endo Pharmaceuticals agreed to acquire American Medical Systems for $30.00 per share, approximately $2.9 billion including assumed debt, announced April 2011 and completed June 2011. The transaction diversified Endo beyond specialty pharma into urology and pelvic-health medical devices (incontinence, ED, BPH and prolapse implants) as a hedge against its branded-drug patent cliffs. Endo later divested the Men's Health business to Boston Scientific in 2015 and wound down Women's Health amid pelvic-mesh litigation.
Did it work? Outcome assessment
Strategic verdict
Failed to Achieve
Financial impact
Impaired/Written Down
Pipeline outcome
Mixed
Assessment window: 10yr post-close.
Key facts
AnnouncedApr 11, 2011
ClosedJun 17, 2011
Deal value$2.9B
Deal typeAcquisition/Merger
Therapeutic areaUrology, men's/women's pelvic health